37
In band
Moving averages
SMA 200$1.31-55.60%
Company profile
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$198.46M
P/E ratioNone
EPS$-0.33
Beta0.947
Dividend yield0.00%
52-week high$3.07
52-week low$0.53
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
TRDA
Entrada Therapeutics Inc
RSI 41
DTIL
Precision Biosciences Inc
RSI 56
CHRS
Coherus Biosciences Inc
RSI 34
NERV
Minerva Neurosciences Inc
RSI 32
OCGN
Ocugen Inc
RSI 29
ARTV
Artiva Biotherapeutics Inc
RSI 21
RSI alerts for IVVD
An email when IVVD closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:19 PM EDT